• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Immune drug effective for scalp psoriasis

New York - Alefacept, a drug that reduces the activity of certain immune cells, effectively treats scalp psoriasis, Reuters Health reports.

New York

- Alefacept, a drug that reduces certain immune cell activity, effectively treats scalp psoriasis, Reuters Health reports.

The study, published in the Journal of the American Academy of Dermatology, evaluated the safety and efficacy of alefacept in treating scalp psoriasis in 30 adults, who received weekly injections for 16 weeks, and then no treatment for 12 weeks.

After one or two courses, 16 patients had at least a 75 percent improvement, researchers report.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
3 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.